ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Triphenylphosphine → 4-(piperidin-4-yloxy)-1H-indazole

HRID 1269780
ノート
印刷プレビュー

反応式

HRID 1269780 の反応式
[NH:1]1[C:9]2[CH:8]=[CH:7][CH:6]=[C:5]([OH:10])[C:4]=2[CH:3]=[N:2]1.O[CH:12]1[CH2:17][CH2:16][N:15](C(OC(C)(C)C)=O)[CH2:14][CH2:13]1.C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.N(C(OCC1C=CC=CC=1)=O)=NC(OCC1C=CC=CC=1)=O.ClCCl.Cl.O1CCOCC1>O1CCCC1.CO>[NH:15]1[CH2:16][CH2:17][CH:12]([O:10][C:5]2[CH:6]=[CH:7][CH:8]=[C:9]3[C:4]=2[CH:3]=[N:2][NH:1]3)[CH2:13][CH2:14]1
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 11776TriphenylphosphineHCID 643502Tert-butyl 4-hydroxypiperidine-1-carboxylateHCID 204431481,4-Dioxane hydrochlorideHCID 86593608Dibenzyl azodicarboxylate dichloromethaneHCID 1357424501H-indazol-4-ol

生成物 1

HCID 229336964-(piperidin-4-yloxy)-1H-indazole収率 32%

試薬・触媒・溶媒 2

HCID 887Methanol溶媒HCID 8028Tetrahydrofuran溶媒

実験手順

To a solution of 1H-indazol-4-ol (200 mg, 1.49 mmol) in tetrahydrofuran (10 ml) were added tert-butyl 4-hydroxypiperidine-1-carboxylate (300 mg, 1.49 mmol), triphenylphosphine (430 mg, 1.64 mmol) and a 40%-dibenzyl azodicarboxylate-dichloromethane solution (0.855 ml, 1.79 mmol) at 0° C. After 1 hour, the mixture thus obtained was warmed up to room temperature. After stirring overnight, the reaction solution was concentrated under reduced pressure, and the resulting residue was dissolved in chloroform (30 ml) and washed with a 1M-aqueous sodium hydroxide solution (20 ml). Extraction with chloroform (30 ml) was carried out again and the organic layer was dried over anhydrous magnesium sulfate. The organic layer dried was concentrated under reduced pressure and the resulting residue was purified by a silica gel column chromatography (eluent: hexane/ethyl acetate). The mixture thus obtained was dissolved in methanol (2 ml) and 4N-hydrochloric acid-dioxane (2 ml) was added thereto at room temperature. After 2 hours, the reaction solution was concentrated under reduced pressure, and the resulting residue was dissolved in methanol (5 ml) and the pH was adjusted to 10 by dropwise addition of a 2M aqueous sodium hydroxide solution. The resulting mixed solution was concentrated under reduced pressure, dried and then purified by a silica gel column chromatography (eluent: chloroform/methanol=10/1→chloroform/methanol/(1%-NH3 aq)=10/1) to obtain 4-(piperidin-4-yloxy)-1H-indazole (103 mg, 32%).

後処理

  1. customat 0° C
  2. customthe mixture thus obtained
  3. concentrationthe reaction solution was concentrated under reduced pressure
  4. dissolutionthe resulting residue was dissolved in chloroform (30 ml)
  5. washwashed with a 1M-aqueous sodium hydroxide solution (20 ml)
  6. extractionExtraction with chloroform (30 ml)
  7. dry with materialthe organic layer was dried over anhydrous magnesium sulfate
  8. customThe organic layer dried
  9. concentrationwas concentrated under reduced pressure
  10. customthe resulting residue was purified by a silica gel column chromatography (eluent: hexane/ethyl acetate)
  11. customThe mixture thus obtained
  12. customat room temperature
  13. waitAfter 2 hours
  14. concentrationthe reaction solution was concentrated under reduced pressure
  15. dissolutionthe resulting residue was dissolved in methanol (5 ml)
  16. additionthe pH was adjusted to 10 by dropwise addition of a 2M aqueous sodium hydroxide solution
  17. additionThe resulting mixed solution
  18. concentrationwas concentrated under reduced pressure
  19. customdried
  20. custompurified by a silica gel column chromatography (eluent: chloroform/methanol=10/1→chloroform/methanol/(1%-NH3 aq)=10/1)

出典と根拠

ORDレコード
ord-77bdb2e5ad104e07aaadbea7f47216fa
出典データセット
uspto-grants-2007_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07199147B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート